Objective. To explore the use of willingness-to-pay (WTP) methods with resp
ect to an antagonist of tumour necrosis factor as an antirheumatic drug.
Methods. One hundred and fifteen rheumatoid arthritis (RA) patients at a te
rtiary care centre in Odense, Denmark were interviewed using two WTP approa
ches, the contingent ranking and double-hounded (closed-ended) methods.
Results. The average closed-ended WTP value was DKr581 and the average cont
ingent ranking WTP was DKr643. There were no statistically significant diff
erences in the WTP estimates between the two methods.
Conclusion. It is feasible to use these methods with arthritis patients. If
, as suggested in a number of recent reviews, a major effort is to be put i
nto undertaking economic appraisals of arthritis programmes, then this shou
ld include more cost-benefit studies using WTP approaches of the kind illus
trated in this paper.